Anders Blomgren

870 total citations
19 papers, 722 citations indexed

About

Anders Blomgren is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Anders Blomgren has authored 19 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Anders Blomgren's work include Drug Transport and Resistance Mechanisms (3 papers), Pain Mechanisms and Treatments (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Anders Blomgren is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pain Mechanisms and Treatments (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Anders Blomgren collaborates with scholars based in Sweden, United Kingdom and France. Anders Blomgren's co-authors include Peter M. Zygmunt, Christine Berggren, Kees Ensing, Anna Holmberg, Börje Sellergren, Anders Isaksson, Alain Eschalier, Therése Hansson, Christophe Mallet and Lisa Walther and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Anders Blomgren

19 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Blomgren Sweden 13 166 163 118 113 92 19 722
W. Nikolaus Kühn‐Velten Germany 15 135 0.8× 126 0.8× 241 2.0× 66 0.6× 36 0.4× 41 1.0k
J. Girault France 19 147 0.9× 81 0.5× 178 1.5× 180 1.6× 32 0.3× 47 1.2k
Richard A. Okerholm United States 18 170 1.0× 109 0.7× 163 1.4× 31 0.3× 45 0.5× 36 842
C.J. van Boxtel Netherlands 20 84 0.5× 92 0.6× 98 0.8× 22 0.2× 50 0.5× 47 893
Edmund Grześkowiak Poland 15 166 1.0× 56 0.3× 179 1.5× 43 0.4× 50 0.5× 126 968
James C. Kraner United States 18 108 0.7× 93 0.6× 165 1.4× 120 1.1× 33 0.4× 51 1.2k
Fuchao Chen China 17 103 0.6× 117 0.7× 308 2.6× 45 0.4× 41 0.4× 63 983
Carlos A. Taira Argentina 20 207 1.2× 182 1.1× 463 3.9× 27 0.2× 47 0.5× 99 1.7k
C. A. M. van Ginneken Netherlands 21 507 3.1× 106 0.7× 236 2.0× 36 0.3× 84 0.9× 79 1.2k

Countries citing papers authored by Anders Blomgren

Since Specialization
Citations

This map shows the geographic impact of Anders Blomgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Blomgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Blomgren more than expected).

Fields of papers citing papers by Anders Blomgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Blomgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Blomgren. The network helps show where Anders Blomgren may publish in the future.

Co-authorship network of co-authors of Anders Blomgren

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Blomgren. A scholar is included among the top collaborators of Anders Blomgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Blomgren. Anders Blomgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Brattsand, Göran, Staffan Lundstedt, Elisabeth Aardal, et al.. (2023). Salivary cortisol and cortisone in diagnosis of Cushing’s syndrome – a comparison of six different analytical methods. Clinical Chemistry and Laboratory Medicine (CCLM). 61(10). 1780–1791. 4 indexed citations
2.
Hansson, Karin, et al.. (2021). Simultaneous determination of folate and methotrexate metabolites in serum by LC-MS/MS during high-dose methotrexate therapy. Journal of Chromatography B. 1186. 123007–123007. 10 indexed citations
3.
Nilsson, Johan, Christophe Mallet, Kiseko Shionoya, et al.. (2020). Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity. European Journal of Medicinal Chemistry. 213. 113042–113042. 10 indexed citations
4.
Nilsson, Johan, Anders Blomgren, Ulf J. Nilsson, Edward D. Högestätt, & Lars Grundemar. (2018). N,N’‐Bis(2‐mercaptoethyl)isophthalamide Binds Electrophilic Paracetamol Metabolites and Prevents Paracetamol‐Induced Liver Toxicity. Basic & Clinical Pharmacology & Toxicology. 123(5). 589–593. 3 indexed citations
6.
Mirrasekhian, Elahe, Johan Nilsson, Kiseko Shionoya, et al.. (2018). The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1‐mediated hypothermia and is associated with prostaglandin inhibition in the brain. The FASEB Journal. 32(10). 5751–5759. 31 indexed citations
7.
Kechagias, Stergios, Anders Blomgren, Therése Hansson, et al.. (2015). Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study. Alcohol and Alcoholism. 50(4). 399–406. 103 indexed citations
8.
Zygmunt, Peter M., Anna Ermund, Pouya Movahed, et al.. (2013). Monoacylglycerols Activate TRPV1 – A Link between Phospholipase C and TRPV1. PLoS ONE. 8(12). e81618–e81618. 131 indexed citations
9.
Barrière, David André, Christophe Mallet, Anders Blomgren, et al.. (2013). Fatty Acid Amide Hydrolase-Dependent Generation of Antinociceptive Drug Metabolites Acting on TRPV1 in the Brain. PLoS ONE. 8(8). e70690–e70690. 52 indexed citations
10.
Hendrickx, Ramon, et al.. (2013). Identification of Novel Substrates and Structure–Activity Relationship of Cellular Uptake Mediated by Human Organic Cation Transporters 1 and 2. Journal of Medicinal Chemistry. 56(18). 7232–7242. 84 indexed citations
11.
Ur-Rehman, Tofeeq, Anatoly Slepenkin, Anders Blomgren, et al.. (2012). Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion. The Journal of Antibiotics. 65(8). 397–404. 31 indexed citations
12.
Ur-Rehman, Tofeeq, et al.. (2012). Preliminary Pharmacokinetics of the Bacterial Virulence Inhibitor N′-(3,5-Dibromo-2-Hydroxy-Benzylidenene)-Nicotinic Acid Hydrazide. Advances in experimental medicine and biology. 954. 349–356. 4 indexed citations
13.
Wu, Kai, et al.. (2009). Budesonide and Ciclesonide: Effect of Tissue Binding on Pulmonary Receptor Binding. Drug Metabolism and Disposition. 37(7). 1421–1426. 12 indexed citations
14.
Eirefelt, Stefan, et al.. (2008). Short Inhalation Exposures of the Isolated and Perfused Rat Lung to Respirable Dry Particle Aerosols; the Detailed Pharmacokinetics of Budesonide, Formoterol, and Terbutaline. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(2). 169–180. 22 indexed citations
15.
Middleton, Brian, et al.. (2007). An Optimized Automated Assay for Determination of Metabolic Stability Using Hepatocytes: Assay Validation, Variance Component Analysis, and In Vivo Relevance. Assay and Drug Development Technologies. 5(3). 403–416. 17 indexed citations
16.
17.
Rosenborg, Johan, Thomas Bengtsson, Per Larsson, et al.. (2000). Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. European Journal of Clinical Pharmacology. 56(5). 363–370. 48 indexed citations
18.
Edholm, L.‐E., et al.. (1992). Automated bioanalysis of drugs using coupled column liquid chromatography for sample pretreatment aspects of quality assurance and collaborative automated handling of data. Chemometrics and Intelligent Laboratory Systems. 17(2). 233–242. 6 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026